Aclaris Therapeutics, Inc

(NASDAQ:ACRS)

Latest On Aclaris Therapeutics, Inc (ACRS):

Date/Time Type Description Signal Details
2023-05-08 20:31 ESTNewsAclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:15 ESTNewsAclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78MN/A
2023-05-05 23:32 ESTNewsAclaris Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-09 12:31 ESTNewsAclaris Therapeutics: Potential Speculative Play After Zunsemetinib Misses Mark On Hidradenitis SuppurativaN/A
2023-03-06 10:16 ESTNewsAclaris stock falls ~35% as zunsemetinib fails mid-stage study in skin disorderN/A
2023-02-23 11:16 ESTNewsAclaris Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $7.75M beats by $5.76MN/A
2023-01-12 19:02 ESTNewsAclaris Therapeutics (ACRS) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2023-01-10 19:15 ESTNewsAclaris Therapeutics Has Strong Upside Potential, But Shares Could Be LowerN/A
2022-12-02 00:46 ESTNewsGoldman Sachs initiates Aclaris at Buy citing potential in lead assetN/A
2022-11-23 08:47 ESTNewsAclaris Therapeutics names CEO as board chair, COO to take helmN/A
2022-10-06 22:31 ESTNewsAclaris initiated as a buy at BTIG on potential of zunsemetinib for autoimmune conditionsN/A
2022-08-26 00:31 ESTNewsAclaris, Lilly ink patent license deal for Olumiant to treat alopecia areataN/A
2022-08-03 16:47 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.05, revenue of $1.53M misses by $0.08MN/A
2022-08-01 21:32 ESTNewsAclaris Therapeutics gets a new COON/A
2022-06-27 23:02 ESTNewsAclaris Therapeutics appoints Gail Cawkwell as Chief Medical OfficerN/A
2022-05-10 22:48 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.09, revenue of $1.45M misses by $0.22MN/A
2022-02-24 08:00 ESTNewsAclaris Therapeutics GAAP EPS of -$0.37 misses by $0.01, revenue of $1.5M misses by $0.3MN/A
2022-02-23 12:00 ESTNewsAclaris Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-01 22:01 ESTNewsAclaris Therapeutics appoints chief business officerN/A
2022-01-12 00:16 ESTNewsAclaris falls on the exit of medical chiefN/A
2021-11-02 11:16 ESTNewsAclaris Therapeutics EPS misses by $0.07, misses on revenueN/A
2021-10-02 05:32 ESTNewsAclaris Therapeutics (ACRS) Investor Presentation - SlideshowN/A
2021-09-17 12:18 ESTNewsAclaris Therapeutics (ACRS) Presents At 23rd Annual Global Investment Virtual Conference - SlideshowN/A
2021-08-27 23:16 ESTNewsAclaris announces proposed settlement of shareholder derivative actionN/A
2021-08-05 21:07 ESTNewsAclaris Therapeutics EPS misses by $0.06, beats on revenueN/A
2021-07-24 07:16 ESTNewsAclaris price target raised at Jefferies citing ‘significant stock moving event’N/A
2021-07-20 17:52 ESTNewsAclaris Therapeutics posts promising data from mid-stage atopic dermatitis trialN/A
2021-07-20 17:51 ESTNewsAclaris Therapeutics to raise $75M in stock offeringN/A
2021-07-20 17:51 ESTNewsAclaris to offer $75M in public offering of stock; shares down 16%N/A
2021-07-20 17:49 ESTNewsAclaris to meet competition from Incyte in atopic dermatitisN/A
2021-07-20 17:49 ESTNewsAclaris Therapeutics secures $125M capital via equity raiseN/A
2021-05-07 23:03 ESTNewsAclaris Therapeutics EPS misses by $0.29, beats on revenueN/A
2021-03-16 16:01 ESTNewsAclaris Therapeutics (ACRS) Presents At H.C. Wainwright Global Life Sciences Virtual Conference - SlideshowN/A
2021-03-15 16:01 ESTNewsAclaris completes enrollment of mid-stage trial for atopic dermatitisN/A
2021-03-05 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $26.67.Buy
2021-03-03 02:01 ESTNewsAclaris Therapeutics: A Potential Big Pharma Deal May Be In The HorizonN/A
2021-02-26 15:01 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$1.04 is estimated for the 2022 year.Sell
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-25 18:35 ESTNewsAclaris Therapeutics EPS misses by $0.04, beats on revenueN/A
2021-02-22 16:16 ESTNewsAclaris Therapeutics stock spikes after speculation of potential sale (update)N/A
2021-02-02 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $25.Buy
2021-01-21 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $14 to $20.Buy
2021-01-20 13:32 ESTNewsAclaris shares rise 10% after pricing equity offeringN/A
2021-01-20 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.83 to $14.Neutral
2021-01-19 23:31 ESTNewsAclaris Therapeutics readies proposed public offeringN/A
2021-01-19 08:31 ESTNewsAclaris stock surges on positive data from mid-stage rheumatoid arthritis ATI-450 trialN/A
2021-01-16 11:00 ESTNewsStocks To Watch: Earnings Day For Netflix, Intel And Procter & GambleN/A
2020-12-22 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.5 to $5.83.Neutral
2020-12-17 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $4.83 to $5.5.Buy

About Aclaris Therapeutics, Inc (ACRS):

Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound that is in phase 2 clinical trial for the treatment of moderate to severe rheumatoid arthritis, COVID-19, and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is in phase 2a clinical trial to treat moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound for the treatment for psoriasis and/or inflammatory bowel disease, as well as A-101 45% topical solution to treat common warts. It also provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

ACRS Quotes by TradingView

See Advanced Chart

General

  • Name Aclaris Therapeutics, Inc
  • Symbol ACRS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 57
  • Fiscal Year EndDecember
  • IPO Date2015-10-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aclaristx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 156.98
  • Price/Book (Most Recent Quarter) 32.91
  • Enterprise Value Revenue 184.55
  • Enterprise Value EBITDA 0.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.38
  • Operating Margin -749%
  • Return on Assets -36%
  • Return on Equity -95%
  • Revenue 6.48 million
  • Earnings Per Share -$4.17
  • Revenue Per Share $0.15
  • Gross Profit -27989000
  • Quarterly Earnings Growth 44.3%
View More

Highlights

  • Market Capitalization 1.29 billion
  • EBITDA -134348000
  • PE Ratio -1.43
  • PEG Ratio -0.13
  • Analyst Target Price $26.67
  • Book Value Per Share $0.84
View More

Share Statistics

  • Shares Outstanding 51.8 million
  • Shares Float 35.44 million
  • % Held by Insiders 964%
  • % Held by Institutions 66.13%
  • Shares Short 758989
  • Shares Short Prior Month 1.45 million
  • Short Ratio 0.72
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.66
  • 52 Week High $26.5
  • 52 Week Low $0.85
  • 50 Day Moving Average 22.3
  • 200 Day Moving Average 9.26
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aclaris Therapeutics, Inc (ACRS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aclaris Therapeutics, Inc (ACRS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$1.58 million-$0.30-$0.26-15.38%
2020-09-302020-11-04$1.45 million-$0.25-$0.3118.03%
2020-06-302020-08-07$N/A-$0.28-$0.3621.13%
2020-03-312020-05-07$1.41 million-$0.37-$0.381.33%
2019-12-312020-02-25$1.1 million-$0.45-$0.39-16.37%
2019-09-302019-11-07$983000-$1.34-$0.69-94.2%
2019-06-302019-08-08$5.87 million-$1.21-$0.75-62.2%
2019-03-312019-05-08$5.04 million-$0.91-$0.80-13.4%
2018-12-312019-03-18$3.67 million-$0.99-$0.98-0.68%
2018-09-302018-11-06$1.63 million-$1.06-$1.3320.1%
2018-06-302018-08-03$3.68 million-$1.01-$1.097.62%
2018-03-312018-05-08$1.12 million-$0.98-$1.002.32%
2017-12-312018-03-12$999000-$0.74-$0.8815.91%
2017-09-302017-11-07$684000-$0.63-$0.8727.59%
2017-06-302017-08-08$N/A-$0.56-$0.7323.29%
2017-03-312017-05-09$N/A-$0.48-$0.5918.64%
2016-12-312017-03-15$N/A-$0.49-$0.6422.83%
2016-09-302016-11-03$N/A-$0.50-$0.6725.65%
2016-06-302016-08-11$N/A-$0.62-$0.654.13%
2016-03-312016-05-11$N/A-$0.65-$0.50-30%
2015-12-312016-03-23$N/A-$0.28-$0.4537.78%
2015-09-302015-10-13$N/A-$5.11-$2.84-79.93%

Aclaris Therapeutics, Inc (ACRS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 8.96 million 6.87 million N/A 9.44 million 64.9 million
Income Before Tax -13.78 million -10.66 million N/A -15.33 million -19.45 million
Selling General Administrative 4.9 million 3.86 million N/A 6.2 million 6.61 million
Gross Profit 294000 260000 N/A 138000 52.36 million
Ebit -13.78 million -9.87 million N/A -14.93 million -19.14 million
Operating Income -13.56 million -10.47 million N/A -15.51 million -19.14 million
Income Tax Expense -182000 N/A N/A N/A N/A
Total Revenue 1.58 million 1.45 million N/A 1.41 million 1.1 million
Cost of Revenue 1.29 million 1.19 million N/A 1.27 million -51.27 million
Total Other Income Expense Net N/A -194000 N/A 178000 -305000
Net Income From Continuing Operations -13.6 million -10.66 million N/A -15.33 million -19.45 million
Net Income Applicable to Common Shares -13.17 million N/A -11.6 million -15.59 million -18.59 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 5.24 million -10.49 million N/A 22.52 million N/A
Change to Liabilities N/A N/A -4.32 million -6.21 million N/A
Total Cash Flow from Investing Activities N/A N/A 13.94 million 56.44 million N/A
Net Borrowings N/A N/A 10.89 million -30.13 million N/A
Total Cash Flow from Financial Activities -278000 -97000 N/A -30.01 million N/A
Change to Operating Activities N/A N/A 2.57 million -9.43 million N/A
Change in Cash -7.19 million -21.41 million N/A 6.04 million N/A
Total Cash from Operating Activities -12.15 million -10.82 million -6.81 million -20.39 million N/A
Depreciation 591000 606000 N/A 5.05 million N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A 3000 N/A
Change to Account Receivables -112000 158000 N/A 12.19 million N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A N/A 5.22 million -3.4 million N/A
Capital Expenditures 304000 17000 N/A 266000 N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 33.13 million 31.15 million 35.63 million 38.64 million 28.39 million
Total Stockholder Equity 37.65 million 40.76 million 49.37 million 58.18 million 69.91 million
Other Current Liabilities 3.71 million 3.3 million 2.29 million 2.66 million 4.16 million
Total Assets 70.78 million 71.9 million 85 million 96.81 million 98.3 million
Common Stock N/A N/A N/A N/A N/A
Other Current Assets 2.59 million 1.75 million N/A N/A 4.97 million
Retained Earnings -504.54 million -491.37 million -480.71 million -469.11 million -453.53 million
Other Liabilities N/A 7.74 million N/A 4.06 million 5.95 million
Other Assets N/A 4.84 million N/A 151000 4.83 million
Cash 22.06 million 23.64 million 32.59 million 53.99 million 35.94 million
Total Current Liabilities 14.87 million 12.79 million 17.75 million 20.6 million 22.43 million
Other Stockholder Equity -94000 -44000 N/A 47000 -66000
Property, Plant & Equipment 1.65 million 1.92 million N/A 6.77 million 2.47 million
Total Current Assets 57.49 million 58 million 70.96 million 82.71 million 83.8 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 30.53 million 33.62 million 51 million 51 million 62.71 million
Short Term Investments 32.07 million 29.83 million 35.53 million 25.01 million 39.08 million
Long Term Debt 10.65 million 10.61 million 10.57 million 10.57 million N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 11.16 million 5.08 million 5.5 million 6.95 million 9.92 million

Aclaris Therapeutics, Inc (ACRS) Chart:

Aclaris Therapeutics, Inc (ACRS) News:

Below you will find a list of latest news for Aclaris Therapeutics, Inc (ACRS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aclaris Therapeutics, Inc (ACRS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-02-200.53.3CALL0 250TRUE00
2026-02-2012.49CALL0 230TRUE00
2026-02-201.53.18CALL0 1360TRUE00
2026-02-2021.75CALL15 2975272.59TRUE1.750
2026-02-2030.9CALL1 5454207.01TRUE0.170.23
2026-02-2040.32CALL0 677341.22FALSE00
2026-02-2050.1CALL5 526170.12FALSE0.10
2026-02-2060.12CALL0 73617.49FALSE00
2026-02-2070.1CALL0 1673.9FALSE00
2026-02-2080.05CALL0 1719.76FALSE00
2026-02-200.50PUT0 00FALSE00
2026-02-2010PUT0 00FALSE00
2026-02-201.50PUT0 01106.92FALSE00
2026-02-2020.1PUT0 169319.93FALSE00
2026-02-2030.2PUT0 2594303.39FALSE00
2026-02-2040.85PUT0 976162.04TRUE00
2026-02-2051.35PUT0 15325.68TRUE00
2026-02-2060PUT0 0332.1TRUE00
2026-02-2070PUT0 0334.14TRUE00
2026-02-2080PUT0 0375.02TRUE00
2026-03-2013CALL0 5185.01TRUE00
2026-03-2021.75CALL0 140TRUE00
2026-03-2031.04CALL0 1219.53TRUE00
2026-03-2040.7CALL0 83169.9FALSE00
2026-03-2050.8CALL0 15246.77FALSE00
2026-03-2060.25CALL0 34327.36FALSE00
2026-03-2070CALL0 0357.36FALSE00
2026-03-2080CALL0 0381.74FALSE00
2026-03-2010PUT0 01367.23FALSE00
2026-03-2020PUT0 0396.08FALSE00
2026-03-2030.41PUT0 19318.14FALSE00
2026-03-2040PUT0 0160.33TRUE00
2026-03-2051.55PUT0 107153.19TRUE00
2026-03-2060PUT0 0179.1TRUE00
2026-03-2070PUT0 0149.11TRUE00
2026-03-2080PUT0 0169.93TRUE00
2026-05-150.54.03CALL0 520TRUE00
2026-05-1512.25CALL0 150TRUE00
2026-05-151.52.3CALL0 230TRUE00
2026-05-1522.75CALL0 28123.51TRUE00
2026-05-1531.25CALL1 263126.94TRUE1.250
2026-05-1540.8CALL1 220121.35FALSE0.80
2026-05-1550.5CALL0 1369123.91FALSE00
2026-05-1560.6CALL0 21209.02FALSE00
2026-05-1570.3CALL0 5194.93FALSE00
2026-05-1580CALL0 0210.51FALSE00
2026-05-150.50PUT0 00FALSE00
2026-05-1510PUT0 0888FALSE00
2026-05-151.50PUT0 0460.89FALSE00
2026-05-1520.2PUT0 12280.58FALSE00
2026-05-1530PUT0 0142.11FALSE00
2026-05-1540.87PUT0 6145.17TRUE00
2026-05-1551.8PUT0 1144.68TRUE00
2026-05-1562.8PUT0 1132.63TRUE00
2026-05-1570PUT0 0136.81TRUE00
2026-05-1580PUT0 0135.11TRUE00
2026-08-2110CALL0 00TRUE00
2026-08-2120CALL0 0123.12TRUE00
2026-08-2130CALL0 0110.88TRUE00
2026-08-2141.05CALL0 10118FALSE00
2026-08-2151.42CALL0 8118.76FALSE00
2026-08-2161.05CALL0 6122.4FALSE00
2026-08-2171CALL0 1159.37FALSE00
2026-08-2180CALL0 0125.1FALSE00
2026-08-2110PUT0 0415FALSE00
2026-08-2120.3PUT0 15207.79FALSE00
2026-08-2130PUT0 0121.76FALSE00
2026-08-2140PUT0 0118.6TRUE00
2026-08-2150PUT0 0125.2TRUE00
2026-08-2160PUT0 0125.16TRUE00
2026-08-2170PUT0 0130.23TRUE00
2026-08-2180PUT0 0132.36TRUE00
2026-12-180.53.1CALL0 30TRUE00
2026-12-1813.6CALL0 1128.18TRUE00
2026-12-181.51.9CALL0 11115.42TRUE00
2026-12-1822.05CALL0 1887119.66TRUE00
2026-12-1831.69CALL0 1622119.25TRUE00
2026-12-1841.5CALL0 734115.85FALSE00
2026-12-1851.55CALL0 107107.36FALSE00
2026-12-180.50PUT0 00FALSE00
2026-12-1810.05PUT0 30FALSE00
2026-12-181.50.25PUT0 3272.51FALSE00
2026-12-1820.45PUT0 1136.6FALSE00
2026-12-1831PUT0 4118.9FALSE00
2026-12-1841.55PUT0 1915111.26TRUE00
2026-12-1852.28PUT0 2112.2TRUE00
2027-01-1510CALL0 0137.05TRUE00
2027-01-1520CALL0 0117.62TRUE00
2027-01-1530CALL0 0109.25TRUE00
2027-01-1540CALL0 0106.79FALSE00
2027-01-1550CALL0 0117.26FALSE00
2027-01-1570CALL0 0108.58FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 0121.15FALSE00
2027-01-1530PUT0 0119.01FALSE00
2027-01-1540PUT0 0123.02TRUE00
2027-01-1550PUT0 0111.69TRUE00
2027-01-1570PUT0 0109.28TRUE00

Latest ACRS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST80$12.925
Jun 13, 2022 7:59 PM EST22$12.935
Jun 13, 2022 7:59 PM EST19$12.93
Jun 13, 2022 7:59 PM EST24$12.93
Jun 13, 2022 7:59 PM EST5$12.93

Aclaris Therapeutics, Inc (ACRS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2020-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1557746/000000000020002443/0000000000-20-002443-index.htm
2019-01-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877719000005/0000038777-19-000005-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877720000013/0000038777-20-000013-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000021545719003192/0000215457-19-003192-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506619000849/0000315066-19-000849-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506620000819/0000315066-20-000819-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720004757/0000834237-20-004757-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720009989/0000834237-20-009989-index.htm
2019-08-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542119000589/0000895421-19-000589-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000139/0000895421-20-000139-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000278/0000895421-20-000278-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2019-10-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445419000691/0000904454-19-000691-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000171/0000904454-20-000171-index.htm
2020-07-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000503/0000904454-20-000503-index.htm
2019-07-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514819000691/0000905148-19-000691-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514820000306/0000905148-20-000306-index.htm
2019-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957419000663/0000919574-19-000663-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957420001125/0000919574-20-001125-index.htm
2019-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002554/0000921895-19-002554-index.htm
2019-11-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002853/0000921895-19-002853-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519003037/0000921895-19-003037-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000093583620000140/0000935836-20-000140-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000103738920000090/0001037389-20-000090-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465919049176/0001104659-19-049176-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920021847/0001104659-20-021847-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920030172/0001104659-20-030172-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920033094/0001104659-20-033094-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1557746/000110465920033140/0001104659-20-033140-index.htm
2020-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1557746/000110465920050082/0001104659-20-050082-index.htm
2020-04-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920053341/0001104659-20-053341-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920094778/0001104659-20-094778-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920094781/0001104659-20-094781-index.htm
2020-10-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920118249/0001104659-20-118249-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000114420419008093/0001144204-19-008093-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266119001597/0001172661-19-001597-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120000734/0001172661-20-000734-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120002035/0001172661-20-002035-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001435/0001193805-18-001435-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001441/0001193805-18-001441-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000014/0001193805-19-000014-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000067/0001193805-19-000067-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000181/0001193805-19-000181-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-07-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000689/0001193805-19-000689-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380520000193/0001193805-20-000193-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015882/0001209191-19-015882-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015888/0001209191-19-015888-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015892/0001209191-19-015892-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015894/0001209191-19-015894-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015898/0001209191-19-015898-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035829/0001209191-19-035829-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035830/0001209191-19-035830-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035832/0001209191-19-035832-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035835/0001209191-19-035835-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035840/0001209191-19-035840-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035916/0001209191-19-035916-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041174/0001209191-19-041174-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041175/0001209191-19-041175-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119054623/0001209191-19-054623-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002761/0001209191-20-002761-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002767/0001209191-20-002767-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035025/0001209191-20-035025-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035056/0001209191-20-035056-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000123191920000022/0001231919-20-000022-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837018009771/0001558370-18-009771-index.htm
2019-01-188-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000179/0001558370-19-000179-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000521/0001558370-19-000521-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002208/0001558370-19-002208-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/0001558370-19-002211-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002649/0001558370-19-002649-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002790/0001558370-19-002790-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003262/0001558370-19-003262-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003265/0001558370-19-003265-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019004465/0001558370-19-004465-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019004494/0001558370-19-004494-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005495/0001558370-19-005495-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005542/0001558370-19-005542-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005736/0001558370-19-005736-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006015/0001558370-19-006015-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006557/0001558370-19-006557-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019007711/0001558370-19-007711-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019007745/0001558370-19-007745-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008497/0001558370-19-008497-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008709/0001558370-19-008709-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008878/0001558370-19-008878-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008933/0001558370-19-008933-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019010383/0001558370-19-010383-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019010425/0001558370-19-010425-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011167/0001558370-19-011167-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011272/0001558370-19-011272-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000075/0001558370-20-000075-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000132/0001558370-20-000132-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020001319/0001558370-20-001319-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837020001325/0001558370-20-001325-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020003444/0001558370-20-003444-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004176/0001558370-20-004176-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004178/0001558370-20-004178-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005715/0001558370-20-005715-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020005744/0001558370-20-005744-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005771/0001558370-20-005771-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006658/0001558370-20-006658-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006989/0001558370-20-006989-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007276/0001558370-20-007276-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007565/0001558370-20-007565-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007743/0001558370-20-007743-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020009808/0001558370-20-009808-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020009814/0001558370-20-009814-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020010689/0001558370-20-010689-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020011154/0001558370-20-011154-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020012486/0001558370-20-012486-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020012488/0001558370-20-012488-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000161577419002509/0001615774-19-002509-index.htm
2020-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1557746/999999999520000907/9999999995-20-000907-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999718009613/9999999997-18-009613-index.htm
2019-05-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999719004164/9999999997-19-004164-index.htm

Aclaris Therapeutics, Inc (ACRS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc (ACRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 964%
Institutional Ownership: 6613%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Neal WalkerPresident and CEOBuy96,150.001,025,053.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-03-02Kamil Ali-JacksonChief Legal OfficerBuy17,175.00103,978.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-02Neal WalkerPresident and CEOBuy52,564.001,049,994.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-01David N. GordonChief Medical OfficerBuy87,500.00106,940.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2019-06-26James E Flynn10% Share HolderSell352.004.501,584.531,072,775.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell10,634.004.5147,947.641,073,127.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell13,063.004.5259,077.421,083,761.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell70,135.004.62323,701.081,096,824.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2020-06-01Neal WalkerPresident and CEOBuy73,014.001,107,907.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2019-05-10James E Flynn10% Share HolderSell71,869.006.05434,749.951,166,959.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-09-01Neal WalkerPresident and CEOBuy83,092.001,170,023.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2019-02-01Brett FairChief Commercial OfficerBuy3,875.0011,890.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-05-09James E Flynn10% Share HolderSell172,800.006.161,064,016.001,238,828.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-06-01Kamil Ali-JacksonChief Legal OfficerBuy33,188.00132,387.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2018-12-15Christopher PowalaChief Reg & Develop OfficerBuy1,300.00138,621.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-18Christopher PowalaChief Reg & Develop OfficerBuy1,625.00139,889.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2019-02-01Christopher PowalaChief Reg & Develop OfficerBuy3,400.00142,843.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2018-12-15Frank RuffoChief Financial OfficerBuy1,300.00161,885.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2020-06-06Anand MehraDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-06ANDREW N SCHIFFDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-06Bryan M. ReasonsDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-06-06William D. HumphriesDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2018-12-18Frank RuffoChief Financial OfficerBuy1,250.00162,765.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2020-03-02Christopher P. MolineauxDirectorBuy8,876.0016,558.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2019-12-16Frank RuffoChief Financial OfficerBuy1,300.00166,276.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-02-01Frank RuffoChief Financial OfficerBuy3,875.00166,284.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2020-06-06Andrew Kenneth William PowellDirectorBuy7,333.0016,709.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2019-12-18Frank RuffoChief Financial OfficerBuy1,250.00167,156.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2020-02-03Frank RuffoChief Financial OfficerBuy3,875.00170,675.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-03-02Frank RuffoChief Financial OfficerBuy25,750.00195,117.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-06-01Frank RuffoChief Financial OfficerBuy33,188.00221,143.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-06Christopher P. MolineauxDirectorBuy7,333.0023,891.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-03-02David N. GordonChief Medical OfficerBuy20,600.0024,952.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2018-12-15Stuart ShanlerChief Scientific OfficerBuy1,300.00268,812.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-18Stuart ShanlerChief Scientific OfficerBuy1,450.00269,892.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2019-02-01Stuart ShanlerChief Scientific OfficerBuy3,875.00273,355.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-06-27James E Flynn10% Share HolderSell590,801.002.691,589,668.253,159,165.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-06-26James E Flynn10% Share HolderSell1,352.004.506,086.033,749,966.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell40,850.004.51184,188.573,751,318.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell50,177.004.52226,925.483,792,168.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell269,402.004.621,243,397.993,842,345.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-05-10James E Flynn10% Share HolderSell108,696.006.05657,523.844,111,747.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-05-09James E Flynn10% Share HolderSell261,345.006.161,609,231.844,220,443.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-03-02MAXINE GOWENDirectorBuy4,438.004,438.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2019-07-02David N. GordonChief Medical OfficerBuy6,000.006,000.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2018-12-15Kamil Ali-JacksonChief Legal OfficerBuy1,733.0079,369.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0079,951.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2019-02-01Kamil Ali-JacksonChief Legal OfficerBuy3,875.0083,520.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-12-16Kamil Ali-JacksonChief Legal OfficerBuy1,733.0083,945.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0084,523.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2018-12-18Brett FairChief Commercial OfficerBuy1,750.008,513.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2020-02-03Kamil Ali-JacksonChief Legal OfficerBuy3,875.0088,121.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-03-02Anand MehraDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-02ANDREW N SCHIFFDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-02Bryan M. ReasonsDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-02William D. HumphriesDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-07-02David N. GordonChief Medical OfficerBuy6,000.0088,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2018-12-15Neal WalkerPresident and CEOBuy3,033.00908,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-18Neal WalkerPresident and CEOBuy2,925.00910,957.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2019-12-16Neal WalkerPresident and CEOBuy3,033.00920,378.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-02-01Neal WalkerPresident and CEOBuy10,800.00920,924.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-12-18Neal WalkerPresident and CEOBuy2,925.00922,521.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-02-03Neal WalkerPresident and CEOBuy10,800.00932,578.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-02Andrew Kenneth William PowellDirectorBuy8,876.009,376.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2019-06-27James E Flynn10% Share HolderSell108,674.002.69292,409.13964,101.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm